Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

Feasibility of 18F-FDG dose reductions in whole body hybrid TOF PET/MR

Yuanfan Xu, Jiangtao Liang, Shifeng Wang, Fangxiao Wang and Feng LI
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 500;
Yuanfan Xu
1Hangzhou Universal Imaging Diagnostic Center Hangzhou China
2Hangzhou Universal Imaging Diagnostic Center Hangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiangtao Liang
1Hangzhou Universal Imaging Diagnostic Center Hangzhou China
2Hangzhou Universal Imaging Diagnostic Center Hangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shifeng Wang
1Hangzhou Universal Imaging Diagnostic Center Hangzhou China
2Hangzhou Universal Imaging Diagnostic Center Hangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fangxiao Wang
1Hangzhou Universal Imaging Diagnostic Center Hangzhou China
2Hangzhou Universal Imaging Diagnostic Center Hangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng LI
1Hangzhou Universal Imaging Diagnostic Center Hangzhou China
2Hangzhou Universal Imaging Diagnostic Center Hangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

500

Objectives: The study aims to investigate the feasibility of reduced tracer dose in 18F-FDG whole body integrated PET/MR imaging and its effects on the semi-quantification analysis and lesion detection.

Methods: 20 patients (41.85±22.42 y; BMI 20.40±4.20 kg/m2) with malignant tumors were performed 6min/bed whole body PET/MR (GE SIGNA) imaging with respiratory gating at 44.60±2.28min after injected standard dose (3.70MBq/kg). The imaging of reduced doses was simulated by reconstruction with 100%, 75%, 50% and 25% of the original data, and the abilities of lesion detection were compared among simulated images of different doses. The signal-to-noise ratio (SNR), SUVmax and SUVmean of liver background in each simulated dose were analyzed by paired t test while the SUVmax, SUVmean, metabolic tumor volume (MTV), total lesion glycolysis (TLG) of the lesions and the image quality score by visualization were analyzed with Wilcoxon test.

Results: The image SNR decreased significantly (t=5.040, 9.638, 11.166, P < 0.01) and the SUVmax of liver background increased (t=3.466, 4.974, 6.964, P < 0.05) with reduced dose. No significant difference was found both in the SUVmean(t=0.567, 0.442, 0.269, P>0.05) of liver background and lesions at each dose, as well as in the SUVmax(Z=-0.673, -0.797, P>0.05), SUVmean(Z=-1.924, -1.127, P>0.05), MTV(Z=-0.43, -1.080, P>0.05) and TLG(Z=-0.615, -1.958,P>0.05) of lesions at 100%, 75%, and 50% simulated dose Yet at 25% simulated dose, the SUVmax was significant higher than that of 100% with 6% deviation (Z=-2.141,P < 0.05), and the MTV and TLG of lesions were much lower with 24%, 18% deviation respectively (Z=-2.107, -2.550, P < 0.05). There was no significant difference for the image quality score between 100% dose and 75% simulated dose (Z=-0.703, P > 0.05), but the image quality scores for both doses were significant higher than that of 50% and 25%( Z=-2.384, -3.746,P < 0.05). The 283 PET-positive lesions have been detected in images from both 75% and 50% simulated doses, while in 25% simulated dose image, 12 lesions were missed, and 8 false-positive lesions were detected.

Conclusions: A 1.85Mbq/kg dose can be feasible in 18F-FDG PET/MR 6min/bed whole body examination. The detection rate and semi-quantitative analysis results will not be affected. It’s not suggested to do imaging with too low dose in case of potential deviation of semi-quantification analysis and lesion detection, and prolonged scan duration should be applied when necessary.Male, 32 years old, right lung cancer with extensive lymph node and bone metastasis. The signal-to-noise ratio (SNR) of simulated dose images reconstructed with 100% (a, e,i), 75% (b, f, j), 50% (c, g, k), 25% (d, h, l) decreased in turn. MIP images showed that the lesions in 100% (a) dose simulated images could be clearly displayed in 75% (b) and 50% (c) simulated dose images. (red arrow) False positive lesion appeared in 25% simulated dose images. (blue arrow) The right acetabulum lesions could be clearly displayed on100%, 75% and 50% dose simulated images, while 25% of dose simulated images were missed the lesion.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility of 18F-FDG dose reductions in whole body hybrid TOF PET/MR
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Feasibility of 18F-FDG dose reductions in whole body hybrid TOF PET/MR
Yuanfan Xu, Jiangtao Liang, Shifeng Wang, Fangxiao Wang, Feng LI
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 500;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Feasibility of 18F-FDG dose reductions in whole body hybrid TOF PET/MR
Yuanfan Xu, Jiangtao Liang, Shifeng Wang, Fangxiao Wang, Feng LI
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 500;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Assessment of incidental pituitary uptake on FDG PET/CT scan: Digital vs. conventional PET/CT
  • Thyroglobulin measurement in fine-needle aspiration optimize lateral neck dissection in patients with papillary thyroid cancer
Show more Oncology: Clinical Therapy and Diagnosis

Miscellaneous

  • Weight Loss as Indication for FDG PET/CT
  • Ultra-fast Whole-body Na18F PET/CT using digital photon counting PET technology: A Clinical Feasibility Study
  • SPECT/CT imaging is essential in accurately determining Curie score derived from I123 MIBG scan in patients with neuroblastoma
Show more Miscellaneous

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire